Weekly Research Analysts’ Ratings Changes for Bath & Body Works (BBWI)

A number of research firms have changed their ratings and price targets for Bath & Body Works (NYSE: BBWI):

• 11/24/2025 – Bath & Body Works was given a new $26.00 price target on by analysts at New Street Research.
• 11/24/2025 – Bath & Body Works was downgraded by analysts at Zacks Research from a “hold” rating to a “strong sell” rating.
• 11/21/2025 – Bath & Body Works had its price target lowered by analysts at UBS Group AG from $32.00 to $17.00. They now have a “neutral” rating on the stock.
• 11/21/2025 – Bath & Body Works had its price target lowered by analysts at Citigroup Inc. from $35.00 to $21.00. They now have a “buy” rating on the stock.
• 11/21/2025 – Bath & Body Works had its price target lowered by analysts at Wells Fargo & Company from $33.00 to $25.00. They now have an “overweight” rating on the stock.
• 11/21/2025 – Bath & Body Works was downgraded by analysts at Telsey Advisory Group from an “outperform” rating to a “market perform” rating. They now have a $17.00 price target on the stock, down previously from $38.00.
• 11/21/2025 – Bath & Body Works had its price target lowered by analysts at Barclays PLC from $28.00 to $18.00. They now have an “equal weight” rating on the stock.
• 11/21/2025 – Bath & Body Works had its “equal weight” rating reaffirmed by analysts at Morgan Stanley. They now have a $18.00 price target on the stock, down previously from $43.00.
• 11/21/2025 – Bath & Body Works was downgraded by analysts at Baird R W from a “strong-buy” rating to a “hold” rating.
• 11/20/2025 – Bath & Body Works was downgraded by analysts at The Goldman Sachs Group, Inc. from a “buy” rating to a “neutral” rating. They now have a $17.00 price target on the stock, down previously from $39.00.
• 11/20/2025 – Bath & Body Works had its “neutral” rating reaffirmed by analysts at Robert W. Baird. They now have a $19.00 price target on the stock, down previously from $33.00.
• 11/20/2025 – Bath & Body Works had its price target lowered by analysts at JPMorgan Chase & Co. from $26.00 to $15.00. They now have a “neutral” rating on the stock.
• 11/20/2025 – Bath & Body Works had its price target lowered by analysts at Bank of America Corporation from $40.00 to $32.00. They now have a “buy” rating on the stock.
• 11/20/2025 – Bath & Body Works had its “market perform” rating reaffirmed by analysts at Telsey Advisory Group. They now have a $17.00 price target on the stock, down previously from $38.00.
• 11/13/2025 – Bath & Body Works had its “outperform” rating reaffirmed by analysts at Telsey Advisory Group. They now have a $38.00 price target on the stock.
• 11/12/2025 – Bath & Body Works had its “market perform” rating reaffirmed by analysts at Raymond James Financial, Inc..
• 11/5/2025 – Bath & Body Works had its price target raised by analysts at Morgan Stanley from $40.00 to $43.00. They now have an “overweight” rating on the stock.
• 10/27/2025 – Bath & Body Works had its price target lowered by analysts at Wells Fargo & Company from $44.00 to $33.00. They now have an “overweight” rating on the stock.
• 10/20/2025 – Bath & Body Works had its price target lowered by analysts at Barclays PLC from $32.00 to $28.00. They now have an “equal weight” rating on the stock.
• 10/13/2025 – Bath & Body Works had its price target lowered by analysts at Jefferies Financial Group Inc. from $32.00 to $28.50. They now have a “hold” rating on the stock.
• 10/8/2025 – Bath & Body Works had its “hold (c-)” rating reaffirmed by analysts at Weiss Ratings.
• 10/6/2025 – Bath & Body Works had its “neutral” rating reaffirmed by analysts at JPMorgan Chase & Co.. They now have a $26.00 price target on the stock.

Bath & Body Works Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, December 5th. Investors of record on Friday, November 21st will be given a dividend of $0.20 per share. The ex-dividend date of this dividend is Friday, November 21st. This represents a $0.80 dividend on an annualized basis and a yield of 4.2%. Bath & Body Works’s dividend payout ratio is currently 24.62%.

Insider Buying and Selling

In related news, Director Francis Hondal purchased 3,343 shares of the firm’s stock in a transaction that occurred on Friday, November 21st. The shares were bought at an average price of $14.99 per share, for a total transaction of $50,111.57. Following the completion of the transaction, the director owned 21,554 shares of the company’s stock, valued at approximately $323,094.46. This trade represents a 18.36% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through this link. Also, Director Lucy Brady purchased 3,470 shares of the company’s stock in a transaction that occurred on Friday, November 21st. The stock was bought at an average cost of $14.40 per share, with a total value of $49,968.00. Following the purchase, the director owned 17,482 shares of the company’s stock, valued at $251,740.80. This represents a 24.76% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders have bought 33,513 shares of company stock worth $500,442 in the last quarter. Insiders own 0.27% of the company’s stock.

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.